New Mountain Vantage Advisers, L.L.C. Bellerophon Therapeutics, Inc. Transaction History

New Mountain Vantage Advisers, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.83 - $5.65 $967,649 - $1.43 Million	-252,650 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$5.07 - $8.27 $3.84 Million - $6.26 Million	-756,581 Reduced 74.97%	252,650 $1.31 Million
Q2 2020 Aug 14, 2020	BUY	$9.43 - $20.28 $8.57 Million - $18.4 Million	909,000 Added 906.91%	1,009,231 $12.7 Million
Q1 2020 May 15, 2020	BUY	$3.39 - $18.0 $339,783 - $1.8 Million	100,231 New	100,231 $1.1 Million

44K

Ticker BLPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,545,450
Market Cap $382K
Description
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development...

Get notified when there are updates to the investment portfolio of New Mountain Vantage Advisers, L.L.C., based on Form 13F filings with the SEC.

Stay updated on New Mountain Vantage Advisers, L.L.C. with notifications on news.